Research On The Financial Performance Of Pien Tze Huang Under The Asset-light Operation Mode

Since the beginning of the 21 st century,with the acceleration of the development process,the level of national economic development is also constantly improving,and enterprises will also face various challenges while facing more opportunities.All kinds of enterprises are constantly adjusting their development direction and business strategies to adapt to the rapid development of the society,among which the pharmaceutical industry,as an industry closely related to the lives of the broad masses of the people,has attracted more attention.Especially with the continuous improvement of people’s living standards,people pay more and more attention to the guarantee of quality of life and personal health problems.At the same time,the pharmaceutical industry has also been strongly supported by national policies.After the new medical reform proposed the concept of "advocating pre-disease prevention rather than post-disease treatment",the public pays more attention to the prevention and treatment of diseases.Therefore,the competition in the pharmaceutical industry is becoming more and more fierce.Enterprises are looking for a suitable operation mode for development in order to gain a firm foothold in the market,so as to maximize the benefits.As an important branch of the pharmaceutical industry,the TCM industry is now gradually being understood and relied on by the public.During the COVID-19 period,its important role in targeted treatment has promoted the wide application of TCM and promoted the development of TCM enterprises.Pien Huang as a drug inheritance in one hundred,the brand influence of Chinese old,also under the fierce market competition constantly explore suitable development mode and operation mode,in view of the pharmaceutical industry of heavy asset proportion,high risk situation timely to enterprise into asset light operation mode,enhance the competitiveness.This paper with Pien Huang as the research object,using literature research,case analysis,financial analysis and comparative analysis method,collect Pien Huang years of financial statements data and under the asset-light operation mode,transformation,transformation process,transformation of financial characteristics and financial performance level analysis,and collect the financial data of other companies in the industry for horizontal comparison.Supported by the value chain theory,"smile curve" theory and financial performance evaluation theory,it analyzes the profitability,operation ability,solvency,growth ability and other aspects according to the financial indicators,and compares and analyzes the financial indicators with three well-known enterprises in the industry.Summarize the specific development situation of Pien Tze Huang enterprise and evaluate the implementation effect of its asset-light operation mode,including positive impact,potential risks and solutions.It is hoped that the summary of the above problems will provide data and transformation strategy reference for other pharmaceutical enterprises to transform into an asset-light model.